Cardinal Health has reported revenues of $54.9 billion for the third quarter fiscal year 2025, flat to the same period last ...

Cardinal Health recently approved an increase in its quarterly dividend, a move that aligns with the company's notable 21% price increase last quarter. This uptick came despite a general market ...

Cardinal Health Inc. (NYSE:CAH) on Thursday reported third-quarter 2025 adjusted EPS of $2.35, up 13% year over year, beating ...

Cardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to ...

The company raised its FY25 per-share operating profit estimate for the fourth time since August. New Cardinal Health CEO on how the giant views its Dublin HQ © 2025 ...

DUBLIN, Ohio, May 7, 2025 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) released its 2025 Advanced Therapies Report: Revolutionizing patient care – the promise and potential of cell and ...

Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast for the fourth time, betting on strong demand for costly specialty medicines and branded drugs.

To get a sense of who is truly in control of Cardinal Health, Inc. (NYSE:CAH), it is important to understand the ownership structure of the business. With 84% stake, institutions possess the ...

To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Cardinal Health executives said Thursday that the company has laid off employees to help offset hundreds of ...

In the latest trading session, Cardinal Health (CAH) closed at $134.36, marking a +0.08% move from the previous day. The stock outpaced the S&P 500's daily loss of 2.24%. Elsewhere, the Dow saw a ...

Cardinal Health Inc. (NYSE:CAH) on Thursday reported third-quarter 2025 adjusted EPS of $2.35, up 13% year over year, beating the consensus of $2.17. Sales remained flat at $54.9 billion ...